The Liver, the Heart and the Vascular System
Nov
13
2023
Room 304/306
-
Hynes Convention Center
8:30
- 10:00 AM EST
Speakers
Description
Abstracts
- POINT-OF-CARE ECHOCARDIOGRAPHY TO ASSESS IMPACT OF CIRRHOTIC CARDIOMYOPATHY AND CARDIORENAL BIOMARKERS IN PATIENTS WITH CIRRHOSIS AND REFRACTORY ASCITES
- CARVEDILOL TO PREVENT DECOMPENSATION OF CIRRHOSIS IN PATIENTS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION STRATIFIED BY NOVEL NON-INVASIVE MODEL: AN INTERNATIONAL MULTICENTER STUDY
- MIRNAS EMBEDDED IN HEPATOCYTE DERIVED EXTRACELLULAR VESICLES PROMOTE ENDOTHELIAL CAPILLARIZATION IN CHRONIC LIVER DISEASE
- IMPROVED MEAN ARTERIAL PRESSURE FROM BASELINE TO THE END OF TREATMENT WITH TERLIPRESSIN IS ASSOCIATED WITH HEPATORENAL SYNDROME REVERSAL: A POOLED ANALYSIS OF 3 PHASE III STUDIES
- MEAN ARTERIAL PRESSURE: A TARGET FOR ACUTE KIDNEY INJURY RESPONSE REGARDLESS OF ACUTE KIDNEY INJURY TYPE
- RISK AND PREDICTORS OF HEPATIC DECOMPENSATION IN GREY ZONE PATIENTS BY THE BAVENO VII CRITERIA: A COMPETING RISK ANALYSIS